Propanc Biopharma, Inc. (the "Company”) is developing a novel approach to prevent recurrence and metastasis of solid tumors by using pancreatic proenzymes that target and eradicate cancer stem cells ...

Harrow's Q2 results show promise, but high debt, market challenges, and execution risks loom. Read here for strategies to ...

Madrid's upgrade is part of a trend among analysts, more than a few of whom have become more positive about Kratos's future ...

Read here for more on ClearPoint Neuro (CLPT) stock's Q2 performance, key catalysts like GLP services, and future growth ...

The trading across all segments will resume on Monday, August 18, as Independence Day is marked as an official holiday as per ...

Ten stocks stood firmer on Thursday, defying a lackluster performance in the broader market, thanks to strong earnings and ...

The stock market keeps climbing, seemingly impervious to a fragile U.S. economy, so investors may want to hedge their ...

The U.S. economy seems to be chugging along fairly smoothly, if a little too slowly for some observers' liking. Under the ...

As an investor, it can be difficult to navigate the ups and downs of the market and understand what the movements mean for your portfolio — particularly when you’re seeing constant headlines on the ...

NEW YORK — Most stocks fell on Wall Street Thursday after a disappointing report said inflation was worse last month at the U ...

This AI cloud infrastructure provider has jumped more than 150% in 2025, and its stunning growth rate suggests that more ...

Increasing pressure on Japan’s technology firms to return more cash to shareholders may spur the next phase of corporate ...